Skip to Content
Merck
  • Inhibition of nuclease activity by a splice-switching oligonucleotide targeting deoxyribonuclease 1 mRNA prevents apoptosis progression and prolong viability of normal human CD4+ T-lymphocytes.

Inhibition of nuclease activity by a splice-switching oligonucleotide targeting deoxyribonuclease 1 mRNA prevents apoptosis progression and prolong viability of normal human CD4+ T-lymphocytes.

Biochimie (2020-04-22)
Dmitry D Zhdanov, Anna A Plyasova, Vadim S Pokrovsky, Marina V Pokrovskaya, Svetlana S Alexandrova, Yulia A Gladilina, Nikolay N Sokolov
ABSTRACT

The nuclease activity of deoxyribonuclease 1 (DNase I) is regulated by alternative splicing (AS) of its mRNA. The aim of this study was to define the ability of a splice-switching oligonucleotide (SSO) that base-paired with DNase I pre-mRNA to induce AS and inhibit nuclease activity in human T, B and NK lymphocytes. The SSO for DNase I could significantly downregulate the expression of full-length active DNase I and upregulate a truncated splice variant with a deleted exon 4. Such an induction of AS resulted in inhibition of nuclease activity and slowed apoptosis progression in anti-CD95/FAS stimulated lymphocytes. These results should facilitate further investigations of apoptosis regulation in lymphocytes and demonstrate that SSOs for DNase I are promising cytoprotective agents.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Bendamustine hydrochloride hydrate, ≥98% (HPLC)
Sigma-Aldrich
Cinnabarinic Acid, ≥98% (HPLC)
Sigma-Aldrich
DL-Glyceraldehyde 3-phosphate solution, 45-55 mg/mL in H2O
Sigma-Aldrich
Taurolidine, >97% (NMR), powder
Sigma-Aldrich
6,8-Bis(benzylthio)-octanoic acid, ≥98% (HPLC)